Axiora Medical
Explore our elite portfolio of high-precision orthopedic surgical instruments, trauma fixation platforms, and specialized spinal implants.
Bridging the gap between robotic-assisted precision surgery and heavy-duty, high-integrity medical device manufacturing.
Minimally Invasive Spine Surgery (MISS) has revolutionized patient outcomes globally, leading to shorter hospital stays, reduced post-operative pain, and minimal disruption to surrounding paraspinal muscle tissues. However, the success of MISS is profoundly dependent on the design, precision, and bio-mechanical integrity of the implants and delivery instruments utilized. Surgeons require low-profile, robust fixation assemblies, dynamic expansion options, and reliable cannulated pathways to accomplish complex operations through narrow surgical corridors.
As a leading Custom OEM Minimally Invasive Spine Surgery Implants Factory and Exporter, Axiora Medical Technology (China) Co., Ltd. stands at the nexus of clinical engineering and Industry 4.0 production capabilities. We address critical pain points for global medical device brands by manufacturing highly sophisticated spine implants—such as cannulated pedicle screws, expandable interbody cages, and anterior cervical plate systems—adhering strictly to ISO 13485 standards. Our end-to-end OEM and ODM workflows allow distributors, medical brands, and surgical groups to configure implants that facilitate navigation-assisted insertion, ensure excellent osteointegration, and comply with rigorous regulatory clearances worldwide.
Unveiling our research directions and production integrations for next-generation spinal arthrodesis and motion preservation.
The landscape of spine surgery is moving rapidly from rigid fixation systems to smart, dynamic, and biologically integrated implants. At Axiora, our R&D roadmap focuses on three main technological pillars:
Leveraging electron beam melting (EBM) and selective laser melting (SLM) additive manufacturing methods, we are developing implants that exhibit a customized interconnected pore structure (300–800 microns). This range mimics human trabecular bone, promoting accelerated vascularization and osteoconduction directly through the implant body, leading to faster arthrodesis.
To reduce long-term foreign body presence, our advanced material pipeline includes magnesium alloys and poly-L-lactic acid (PLLA) variants for dynamic load-sharing trauma plates. Furthermore, for our high-demand spine line, we are expanding our custom PEEK manufacturing capabilities to integrate radiolucent, carbon-fiber reinforced structures that permit clear post-operative imaging and artifact-free CT/MRI scanning.
Inside Axiora's 18,600 m² state-of-the-art facility featuring 48 dedicated QC staff and automated production lines.
Our production philosophy combines strict compliance controls with high-throughput automation. By implementing automated Japanese Star and Citizen longitudinal cutting lathes, multi-axis CNC centers, and automated ultrasonic washing units, we eliminate dimensional variance. Our Class 10,000 (ISO Class 7) aseptic packaging cleanrooms guarantee that finished implants meet zero-contamination bioburden standards before sterilization validation.

























Providing global enterprises with robust engineering resources, prototype testing, and supply chain scale.
Medical implant brands face substantial friction during the transition from digital design (CAD) to mass manufacturing. Incompatibilities in tooling tolerances or material processing often lead to high reject rates or post-implantation complications. Axiora bridges this gap by acting as a highly collaborative custom engineering partner.
Analyzing critical procurement parameters: logistics control, verification documentation, and sterile-ready packaging.
B2B hospital buyers, global medical device brands, and ministry of health procurement bodies prioritize absolute risk mitigation over all other factors. A qualified OEM partner must demonstrate stability across three major domains:
Technical facts, manufacturing footprints, and verified operations data of Axiora Medical Technology (China) Co., Ltd.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Operating Factor | Details & Technical Standards |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 |
| Factory Area | 18,600 m² (Equipped with cleanroom structures) |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 Quality Engineers and Metrologists |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Partners | 1,120 global and regional medical device partners |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 advanced designs and kits |
| R&D Engineers | 86 senior mechanical and biomedical engineers |
Navigating country-specific registration, medical translation, and post-market surveillance demands.
Entering distinct regulatory environments requires a deep understanding of local laws. Axiora offers customized documentation packages to simplify localized registration processes. We supply detailed technical files, clinical evaluations, and risk management documentation structured in accordance with ISO 14971 guidelines. This expedites approval by local authorities, such as the FDA in the US, notified bodies under the EU MDR, and other regional regulatory agencies.
Furthermore, our post-market surveillance (PMS) system tracking enables quick reporting and continuous feedback integration. By collaborating with local representatives in key export markets, we ensure that updates regarding quality, surgical feedback, and user requirements are instantly updated in our primary production process, preventing operational disruption.
Clarifying production lead times, quality validation protocols, and custom design procedures.
Ensuring anatomical alignment and high mechanical stability for complex human and veterinary applications.